Prof Kuan-Chen Chen | Performance Management | Best Researcher Award

Posted on 24/05/202524/05/2025 by ScienceFather

Prof Kuan-Chen Chen | Performance Management | Best Researcher Award

National Taipei University of Nursing and Health Sciences, Taiwan

Author Profile

Early Academic Pursuits

Professor Kuan-Chen Chen embarked on his academic journey with a profound interest in the intricate dynamics of finance and its intersection with health care systems. He earned his Ph.D. in Finance from National Chengchi University, one of Taiwan’s most prestigious institutions known for excellence in business and social sciences. During his doctoral studies, Professor Chen exhibited a keen aptitude for analytical reasoning, quantitative modeling, and an interest in macro and micro-level financial systems. This formative academic experience laid the foundation for a career that would eventually bridge the worlds of finance and healthcare management—a rare and essential confluence in today’s complex health economies.

His early academic work reflected a deep engagement with both theoretical models and empirical data, which allowed him to develop a nuanced understanding of how financial principles could be applied to optimize healthcare operations. These academic roots inspired him to explore the evolving financial challenges of healthcare institutions and to delve into research that could influence not only academic scholarship but also real-world practices.

Professional Endeavors

Currently a Professor in the Department of Health Care Management at the National Taipei University of Nursing and Health Sciences (NTUNHS), Professor Chen brings years of academic rigor and practical insight into the classroom and research laboratory. At NTUNHS, he is deeply involved in teaching, research, and academic leadership, offering specialized courses such as financial management, healthcare management, and hospital performance evaluation. These courses are designed not only to impart knowledge but to cultivate critical thinking among future healthcare managers and policymakers.

In parallel with his academic role, Professor Chen has successfully led multiple government-funded research projects, showcasing his ability to secure competitive grants and apply findings to public policy and institutional reforms. He maintains close ties with the healthcare industry, acting as a collaborative partner and advisor, which reinforces the relevance and applicability of his research.

Contributions and Research Focus

Professor Chen’s research portfolio reflects a rich blend of finance, healthcare systems, and policy evaluation. His scholarly work has notably explored working capital management, agency costs, economies of scope, and corporate social responsibility (CSR) within hospital settings.

One of his notable research projects, funded by Taiwan’s National Science Council, titled “The Impact of Working Capital Management on Financial Performance: Empirical Evidence from Hospitals in Taiwan”, addressed critical concerns surrounding liquidity and resource allocation in healthcare institutions. By empirically assessing how hospitals manage their short-term financial assets and liabilities, this study provided strategic insights into improving financial efficiency and service delivery.

Another significant project, “Agency Costs, Economies of Scope, and Corporate Social Responsibility in Hospitals,” reflects his forward-thinking approach toward integrating CSR into the operational fabric of healthcare organizations. This research explores how broader social objectives can coexist with fiscal accountability and institutional efficiency.

His citation metrics further affirm his scholarly influence:

Total Citations: 506
Citations since 2020: 309
h-index: 13 (10 since 2020)
i10-index: 15 (12 since 2020)

These figures highlight the continued relevance and reach of his research across academic and policy-making communities.

Accolades and Recognition

While Professor Chen’s career is marked by impactful research and educational contributions, he has also received recognition for his academic leadership and policy relevance. Being entrusted with multiple government-backed projects is a testament to his credibility and the confidence that both academia and public institutions place in his expertise. His role as a principal investigator in projects that examine the financial underpinnings of Taiwan’s hospital system has further established him as a thought leader in health finance.

Moreover, his active engagement with the healthcare industry reflects not just theoretical depth but also practical understanding—an invaluable combination that places him in demand as a consultant, advisor, and speaker.

Impact and Influence

Professor Chen’s work resonates not just within Taiwan but also has implications for the global discourse on healthcare economics and management. By addressing the dual imperatives of financial sustainability and quality patient care, his research contributes to international conversations on how healthcare systems can navigate the challenges of limited resources, aging populations, and rising costs.

His insights into CSR in hospitals underscore the evolving expectations of healthcare institutions—not merely as providers of clinical services but as socially responsible entities accountable to a wider array of stakeholders, including communities, regulators, and investors.

Through teaching and mentorship, Professor Chen has also cultivated a new generation of scholars and practitioners, many of whom go on to apply his models and methods in diverse institutional settings, thereby multiplying the reach of his impact.

Legacy and Future Contributions

As a respected academic and a prolific researcher, Professor Kuan-Chen Chen is poised to continue his influential work at the nexus of healthcare and financial management. His future research is likely to further explore the digital transformation of healthcare finance, value-based care models, and the role of data analytics in improving hospital performance.

With Taiwan and other nations grappling with health financing reforms, Professor Chen’s work will undoubtedly remain central to shaping policy decisions and institutional strategies. His balanced approach—grounded in rigorous analysis yet attentive to real-world application—ensures that his legacy will not only be scholarly but also deeply practical and socially relevant.

Looking ahead, he is set to expand his collaborations, possibly leading cross-national studies, and contributing to global best practices in hospital financial governance. His journey exemplifies how academic excellence, when combined with a sense of purpose, can leave an enduring imprint on both institutions and society at large.

Notable Publications

Healthcare utilization and costs for patients with Parkinson’s disease in Taiwan

Authors: Kuan-Chen Chen, Li-Jung Elizabeth Ku, Ya-Hui Hu, Yu Sun, Alexis Elbaz, Pei-Chen Lee

Journal: BMC Neurology

Year: 2025

Assoc. Prof. Dr. Junpeng Ma | Team Building and Team Management | Best Researcher Award

Posted on 23/05/202523/05/2025 by ScienceFather

Assoc. Prof. Dr. Junpeng Ma | Team Building and Team Management | Best Researcher Award

sichuan university, China

Author Profile

Scopus

Early Academic Pursuits

Dr. Junpeng Ma began his academic journey in the field of electrical engineering at Southwest Jiaotong University in Chengdu, China. His intellectual curiosity and deep interest in energy systems quickly distinguished him among his peers. He completed his Bachelor of Science (B.S.) degree in 2013, laying a strong foundation in electrical circuits, power electronics, and systems engineering. Fueled by a desire to contribute to the rapidly evolving energy sector, he continued his academic pursuit at the same institution, earning his Ph.D. in 2018. During his doctoral studies, Dr. Ma focused on the intricate dynamics of modern energy systems, with particular attention to renewable energy integration and high-voltage transmission.

In a pivotal phase of his academic development, Dr. Ma expanded his horizons internationally by joining Aalborg University in Denmark as a Guest Ph.D. Student from November 2017 to May 2018. Aalborg is renowned for its excellence in power electronics and smart energy systems, and this experience gave Dr. Ma access to advanced methodologies and a global network of researchers. It not only sharpened his technical acumen but also enriched his cultural and collaborative skills—traits that would become central to his later work as an educator and innovator.

Professional Endeavors

Upon completion of his doctoral degree, Dr. Ma began his professional academic career at Sichuan University, one of China’s most prestigious institutions. He now serves as an Associate Professor in the College of Electrical Engineering, where he combines his passion for teaching with a deep commitment to cutting-edge research. In this role, he has been instrumental in educating future engineers and leading advanced research initiatives in energy systems.

Dr. Ma’s professional focus encompasses both classroom instruction and the development of research projects that address national and global energy challenges. He is actively engaged in supervising graduate students, designing curricula in line with the latest technological trends, and publishing research that informs the design and optimization of power grids. His position enables him to contribute to Sichuan University’s growing reputation in power system innovation while continuing his own journey of academic excellence.

Contributions and Research Focus

Dr. Ma’s research centers on two of the most critical elements of modern energy infrastructure: the modeling and control of new energy clusters and high-voltage direct current (HVDC) systems. As global energy networks pivot toward renewable sources, the challenge of managing their intermittent and decentralized nature has come to the forefront. Dr. Ma’s work addresses these challenges through advanced modeling techniques and control strategies designed to improve reliability and efficiency.

New energy clusters often integrate wind, solar, battery storage, and other distributed energy resources. Dr. Ma develops frameworks that allow these systems to function cohesively under changing environmental and load conditions. In parallel, his research on HVDC systems—which are essential for long-distance power transmission—focuses on optimizing their operation to reduce losses, manage faults, and enable more flexible energy exchange between regions. His contributions in these areas are instrumental in supporting China’s—and the world’s—transition to a low-carbon energy future.

Accolades and Recognition

Dr. Ma’s dedication to impactful research has been recognized through a series of prestigious awards from major scientific and professional bodies. He was awarded the Second Prize of the Science and Technology Progress Award by the China Electrotechnical Society, where he was recognized as the leading contributor (1st out of 10). This accolade reflects the technical depth and relevance of his work in the field of power systems.

He also received the First Prize of the Science and Technology Progress Award from the China Association of Work Safety (2nd out of 15), honoring his contributions to the safety and reliability of energy infrastructure—an area of increasing importance in the era of energy transition. Additionally, he was honored with the Second Prize of the Science and Technology Progress Award of Sichuan Province (3rd out of 8), further affirming his regional influence and scientific merit. These awards underscore his ability to translate complex research into practical innovations that benefit both industry and society.

Impact and Influence

Beyond his academic achievements, Dr. Ma’s work exerts a significant influence on the practical development of smart and sustainable energy systems. His research findings are routinely cited and applied in projects focused on grid modernization and renewable integration. In China’s ambitious move toward energy decarbonization, his contributions support essential initiatives aimed at improving grid flexibility, enhancing power quality, and ensuring energy security.

As an educator, Dr. Ma plays a transformative role in shaping the minds and careers of young engineers. His students are not only equipped with technical skills but are also inspired by his example of research-driven societal contribution. His influence extends beyond the university, as he participates in technical committees, delivers lectures at academic conferences, and collaborates with research institutes and industry partners across China and internationally.

Legacy and Future Contributions

Looking forward, Dr. Junpeng Ma is positioned to be a thought leader and innovator in the global transition toward intelligent, decarbonized energy systems. His continued research promises to yield further breakthroughs in the areas of renewable energy management, smart grid resilience, and advanced control systems for HVDC technologies. These advancements will not only shape technical practices but also inform policy-making and investment in sustainable energy infrastructure.

His legacy will likely be defined by a combination of academic rigor, technological innovation, and societal impact. As he mentors future researchers and deepens his contributions to global energy solutions, Dr. Ma stands as a vital figure in the evolution of electrical engineering in the 21st century. His work today lays the groundwork for a cleaner, smarter, and more resilient energy future for all.

Notable Publications

Prediction Method and Optimal Control of Subsequent Commutation Failure in LCC-HVDC System Based on Dynamic Extinction Angle Equation

Author(s): Zhiwei Lei, Junpeng Ma, Shunliang Wang, Ning Jiao, Tianqi Liu
Journal: Dianli Xitong Baohu yu Kongzhi / Power System Protection and Control
Year: 2025

Stability Analysis of Power Self-Synchronization Control of Grid-Forming Converters in Wide Range of Short-Circuit Ratio Conditions

Author(s): Junpeng Ma, Lei Li, Chengbin Chi, Shunliang Wang, Tianqi Liu
Journal: Dianli Xitong Baohu yu Kongzhi / Power System Protection and Control
Year: 2025

Adaptive Control Strategy of Disturbance Voltage for Impedance Measurement

Author(s): Jingbo Zhao, Qian Zhou, Wenli Yang, Junpeng Ma
Journal: Journal of Power Supply
Year: 2025

A Thyristor-Based Solid-State DC Circuit Breaker With a Three-Winding Coupled Inductor

Author(s): Shunliang Wang, Ming Li, Kejun Qin, Nie Hou, Tianqi Liu
Journal: IEEE Transactions on Power Electronics
Year: 2025

An Asymmetric Hybrid Phase-Leg Modular Multilevel Converter With Small Volume, Low Cost, and DC Fault-Blocking Capability

Author(s): Rui Zhang, Shunliang Wang, Junpeng Ma, Tianqi Liu, Yun Yang
Journal: IEEE Transactions on Power Electronics
Year: 2025

Dr. Yang Xu | Strategic Leadership | Best Researcher Award

Posted on 22/05/2025 by ScienceFather

Dr. Yang Xu | Strategic Leadership | Best Researcher Award

Hubei Medical Devices Quality Supervision and Test Institute, China

Author Profile

Scopus

Early Academic Pursuits

Yang Xu’s journey into the world of engineering and medical device innovation began with a strong academic foundation rooted in applied sciences and engineering principles. Driven by a curiosity about the intersection of technology and human health, Yang pursued rigorous technical education, laying the groundwork for a future in biomedical engineering. From his early academic days, Yang exhibited a meticulous approach to problem-solving and a keen interest in the complex dynamics of electronic systems and their applications in healthcare. This led to his early involvement in research projects focused on the safety and performance of active medical devices—especially ultrasonic surgical instruments.

Throughout his formative academic years, Yang Xu demonstrated a strong aptitude for both theoretical understanding and practical application. This dual capability equipped him with the technical insight required to navigate the multidisciplinary demands of the medical device field. His early work often bridged the gap between laboratory research and clinical application, which would later become a hallmark of his professional contributions.

Professional Endeavors

Yang Xu currently serves as the Dean of the Hubei Medical Devices Quality Supervision and Test Institute, a prestigious role that underscores his leadership in the field of medical device quality and safety. His concurrent position as the Director of the NMPA Key Laboratory for Quality Evaluation of Ultrasonic Surgical Instruments further highlights his specialization in the performance assessment of high-precision surgical technologies.

His extensive career encompasses pivotal roles such as IEC/CISPR Registered Expert, CNAS Assessor, and CMA Expert Reviewer. These positions are a testament to his credibility and technical authority in standards development and compliance. Within the framework of China’s standardization efforts, Yang has made impactful contributions as a member of SAC/TC79/SC2 and SAC/TC246/SC2, where he focuses on radio interference and electromagnetic compatibility (EMC) in industrial and medical devices.

Yang’s leadership extends to influential national platforms. He serves on the Executive Committee of the NMPA Technical Committee on Medical Device Classification and holds a key role in the CISPR/B/WG7, which deals with international EMC standardization for information technology equipment. His engagement with the National Engineering Research Center for Ultrasonic Medicine and as a Clinical Master Co-supervisor at the State Key Lab of Ultrasound in Medicine and Engineering signifies his active involvement in guiding young researchers and engineers.

Contributions and Research Focus

Yang Xu has long been engaged in technical operations related to the inspection, testing, standardization, quality control, and safety evaluation of active medical devices. His expertise particularly centers on electromagnetic compatibility (EMC) and the clinical performance of ultrasonic surgical tools. These contributions have elevated China’s capability to ensure the safety and reliability of emerging medical technologies.

He has played a leading role in three National Key R&D Programs, showcasing his capacity to steer complex, high-impact research projects. Additionally, Yang has contributed to one international standard and eight national standards, reflecting his active involvement in shaping the regulatory landscape of medical devices both in China and internationally.

His academic output includes 37 published papers and contributions to several technical monographs, making him a respected voice in both engineering circles and academic forums.

Accolades and Recognition

Yang Xu’s achievements have earned him widespread recognition across regulatory, academic, and professional communities. His position as a registered expert and assessor with key institutions like CNAS and CMA underscores the trust placed in his technical judgment. His membership in committees across national and international bodies attests to his authority and leadership in standardization and quality evaluation.

His role in drafting national and international standards has been particularly impactful, helping bridge the gap between local regulatory practices and global compliance expectations. Such efforts are often recognized as instrumental in promoting China’s presence in the global medical device quality assurance ecosystem.

Impact and Influence

Through his leadership at the Hubei Medical Devices Institute and various technical committees, Yang Xu has significantly influenced policy-making, quality assurance systems, and the development of performance benchmarks for active medical devices. His work ensures that patients receive safe, effective, and reliable care through rigorously tested and standardized medical technologies.

Moreover, Yang’s role in mentoring young professionals—particularly through his co-supervisory position—has cultivated a new generation of biomedical engineers and clinical researchers who continue to expand on his legacy. His multidisciplinary approach, which combines engineering, clinical validation, and regulatory knowledge, serves as a model for holistic innovation in medical technology.

Legacy and Future Contributions

Yang Xu’s contributions form a legacy of scientific rigor, regulatory advancement, and clinical relevance. His work has enhanced the performance and safety of ultrasonic surgical instruments, contributed to international standardization efforts, and strengthened China’s medical device evaluation infrastructure.

Looking forward, Yang is poised to continue influencing emerging fields like AI-integrated medical devices, minimally invasive ultrasonic surgery, and real-time EMC diagnostics. His ongoing involvement in key research programs and regulatory bodies ensures that his insights will shape the future of healthcare technology in China and beyond.

As a leader, researcher, and mentor, Yang Xu’s dedication to innovation and safety in medical devices stands as a beacon of excellence—setting a high standard for future engineers and scientists in the field.

Notable Publications

An Algorithm of mmWave MIMO Antenna Exposure Based on Unsupervised Deep Learning

Authors: Yang Xu, Haitao Fu, Yawen Liu, Xiong Hui

Journal/Conference: Proceedings of the 7th International Conference on Information Science, Computer Technology and Transportation (ISCTT 2022)

Year: 2022

Dr. Jia Liu | Team Building and Team Management| Best Researcher Award

Posted on 19/05/202519/05/2025 by ScienceFather

Dr. Jia Liu | Team Building and Team Management| Best Researcher Award

Capital Center for Children’s Health, Capital Medical University, China

Author Profile

Orcid

Early Academic Pursuits

Jia Liu began her academic journey with a strong focus on medical sciences, where she pursued an M.D. in Otolaryngology Head and Neck Surgery from Beijing Anzhen Hospital, affiliated with Capital Medical University, between 2013 and 2016. Her dedication to expanding her medical expertise led her to the University of Chicago, USA, in 2015, where she gained invaluable experience as a visiting student. This international exposure enriched her understanding of advanced clinical practices and set the stage for her future career.

Professional Endeavors

After completing her academic training, Jia Liu began her professional career as a resident at Beijing Anzhen Hospital from 2016 to 2019. Here, she honed her clinical skills in otolaryngology, particularly in the diagnosis and treatment of head and neck disorders. Her dedication and growing expertise earned her a position as an attending physician at the Capital Center for Children’s Health, Capital Medical University, in 2019. In this role, she has continued to provide high-quality care while also actively engaging in research, making significant contributions to pediatric otolaryngology.

Contributions and Research Focus

Jia Liu’s research is distinguished by its focus on otolaryngology, with a particular emphasis on olfactory disorders. Her notable project, funded by the Beijing Natural Science Foundation from 2019 to 2020, focused on the “Pedigree study on the molecular mapping, screening, and expression of olfactory genes for isolated congenital anosmia.” This research has advanced the understanding of the genetic basis of olfactory disorders, paving the way for improved diagnostic methods and therapeutic strategies.

Accolades and Recognition

Jia Liu’s dedication and achievements have been recognized through several prestigious awards. In 2014, she received the “Merck Clinical Scholar Award” from the American Academy of Otolaryngic Allergy (AAOA), a recognition of her early potential in the field. The following year, she was awarded a Chinese Government Scholarship from the China Scholarship Council, enabling her to study abroad at the University of Chicago. Her exceptional contributions to medical science were further acknowledged with the Beijing Medical Science and Technology Prize in 2018 and the Chinese Medical Science and Technology Prize in 2019.

Impact and Influence

Jia Liu has significantly impacted the field of otolaryngology, especially in pediatric care. Her clinical expertise and commitment to research have established her as a respected figure in her field. Her work in understanding and treating olfactory disorders has not only advanced scientific knowledge but has also improved clinical practices.

Legacy and Future Contributions

Jia Liu is poised to continue making significant contributions to otolaryngology. Her commitment to exploring the genetic basis of olfactory disorders positions her to lead future breakthroughs in the diagnosis and treatment of these conditions. As she continues her work at the Capital Center for Children’s Health, her legacy as a dedicated clinician and researcher is set to grow.

Notable Publications

Evaluation of brain and neurophysiologic function in isolated congenital anosmia

Author(s): Liu J, Gao X, Zhan X, Lu Y, Yao L, Yi X, Gu Q
Journal: American Journal of Otolaryngology
Year: 2025

The effect of nasopharyngeal obstruction on the olfactory bulb volume and olfactory sulcus depth in children

Author(s): Yao L, Liu J, Xiaoli Yi, Gu Q
Journal: European Archives of Oto-Rhino-Laryngology
Year: 2024

Analysis of clinical characteristics in the patient with olfactory disorders

Author(s): Liu J, Zhan X, Yao L, Xie H, Chang F
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2022

Prognostic value of olfactory bulb volume in patients with post-viral olfactory dysfunction

Author(s): Guo Y, Yao L, Sun Z, Huang X, Liu J, Wei Y
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2022

Predictors of posttreatment olfactory improvement in patients with postviral olfactory dysfunction

Author(s): Guo Y, Yao L, Sun Z, Huang X, Liu J, Wei Y
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2021

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Posted on 17/04/2025 by ScienceFather

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Shanghai AZ Science and Technology Co., Ltd.

Author Profile

Orchid

Early Academic Pursuits

From the very beginning of his academic journey, Dr. Youmin Zhu demonstrated an exceptional passion for biological sciences. His intellectual curiosity led him to pursue a Ph.D. in biological sciences, where he laid a solid foundation in molecular biology, biotechnology, and pharmacology. During his doctoral years, he cultivated a deep interest in cutting-edge therapeutic strategies, particularly focusing on emerging protein degradation technologies and the role of bioactive peptides. His academic rigor and scientific curiosity propelled him to explore innovative modalities that bridged traditional research with real-world applications in drug and skincare development. These formative experiences not only enriched his technical skills but also instilled a vision to contribute meaningfully to both science and society.

Professional Endeavors

Now serving as the R&D President and Chief Scientist at Shanghai AZ Science and Technology Co., Ltd., Dr. Zhu has emerged as a visionary leader in the field of biotechnology. Under his guidance, the organization has completed over 20 major R&D projects, encompassing the development of peptide PROTACs-based skincare ingredients, enzymes, and probiotics. These endeavors reflect not only his scientific expertise but also his ability to translate theoretical concepts into commercial and therapeutic innovations.

Dr. Zhu’s strategic direction in the biotechnology sector has turned his company into a powerhouse of innovation, where the fusion of peptide-based therapeutics and skincare science is leading to transformative solutions. His work has bridged academic excellence with industrial application, enabling breakthroughs in precision medicine and advanced cosmeceuticals.

Contributions and Research Focus

Dr. Zhu’s research focus lies at the intersection of molecular biology, pharmacological innovation, and cosmetic science, with a central emphasis on peptide PROTACs (Proteolysis Targeting Chimeras). His pioneering efforts in this area have highlighted the multi-targeting potential of peptides, their biodegradability, low toxicity, and modular design, all of which present significant advantages over conventional small molecules and antibodies.

One of his most notable contributions is the publication of the article titled “The Peptide PROTAC Modality: A New Strategy for Drug Discovery” in MedComm (2025), an SCI-indexed journal with an impressive impact factor of 10.7. This work has been widely recognized in the scientific community and is already making waves in discussions around next-generation therapeutic strategies. The article has been cited across multiple domains, further demonstrating its relevance and value in ongoing pharmaceutical research.

With a total of over 10 scientific publications, Dr. Zhu has consistently contributed to scholarly literature and advanced dialogue in biotherapeutics. In addition, he holds 18 authorized patents in China, such as Patent No. CN202410445356.X, further underscoring his commitment to translating innovation into intellectual property and practical applications.

Accolades and Recognition

Dr. Zhu’s groundbreaking work has not gone unnoticed. His scientific and entrepreneurial achievements have earned him recognition within academic, industrial, and international circles. In addition to being a contributing scientist to impactful research, he has also been actively involved in collaborative projects with prestigious institutions including Fudan University, Shanghai Jiao Tong University, and Zhejiang University.

He is also an esteemed member of professional networks such as the Chinese Overseas Alliance and the Chinese Doctoral Alliance, where he continues to contribute to thought leadership and global knowledge exchange.

Furthermore, his work was recently highlighted in a widely circulated WeChat feature and an official PDF document of professional certification, showcasing his influence in both academic and industrial spheres.

Impact and Influence

Dr. Zhu’s influence extends beyond scientific circles. His work on peptide PROTACs is helping redefine how we understand and treat complex diseases. By leveraging the natural degradation mechanisms of the body through targeted proteolysis, his innovations are creating new avenues for the treatment of conditions previously considered untreatable.

Equally impressive is his impact on precision skincare, where bioengineered peptide-based compounds are providing customized, low-toxicity solutions for skin health. This cross-disciplinary impact, from health to beauty, positions Dr. Zhu as a transformative figure in the biotech and wellness industries.

His articles, particularly those involving collaborative authorship with Yu Dai and Yuncai Tian, have sparked global interest, and the citation of his MedComm article continues to grow. These ripple effects reflect the profound scientific and commercial value of his work.

Legacy and Future Contributions

As Dr. Zhu continues to push boundaries, the future of peptide-based therapeutics and cosmeceuticals looks increasingly promising. He is paving the way for a new era of precision medicine, where treatments are not only more effective but also safer and more sustainable.

Looking ahead, Dr. Zhu plans to scale his innovations globally and expand his company’s reach into international markets, bringing Chinese biotechnology to the global stage. His future goals include mentoring young scientists, fostering new academic-industry partnerships, and developing a global research ecosystem centered on peptide technologies.

Through his unwavering dedication and strategic foresight, Dr. Youmin Zhu is building a legacy that will inspire a generation of researchers and innovators. His contributions are not only advancing science but also shaping the future of healthcare and skincare for the better.

The Peptide PROTAC Modality: A New Strategy for Drug Discovery

Authors: Youmin Zhu, Yu Dai, Yuncai Tian
Journal: MedComm
Year: 2025

New Nobel Prize MicroRNA Technology Is Opening up a New Era of Precision Skincare

Authors: Youmin Zhu, Yu Dai, Xiaojing Wang, Shengjie Zhu, Yuncai Tian, Yong Tian
Journal: Advanced Journal of Nursing
Year: 2025

New peptide PROTAC is triggering a revolution in precise targeted skincare

Authors: Youmin Zhu, Yu Dai, Yuncai Tian, Yong Tian
Journal: Preprint (platform not specified)
Year: 2024

Advances in CRISPR/Cas9

Authors: Youmin Zhu, Syed Hassan
Journal: BioMed Research International
Year: 2022

Comparative Transcriptomics Reveals Jasmonic Acid-Associated Metabolism Related to Cotton Fiber Initiation

Authors: Liman Wang, Youmin Zhu, Wenjing Hu, Xueying Zhang, Caiping Cai, Wangzhen Guo
Journal: PLOS ONE
Year: 2015

Mr. Asahi Matsubara | leadership | Best Researcher Award |3637

Posted on 09/04/2025 by ScienceFather

Mr. Asahi Matsubara | leadership | Best Researcher Award

Graduate school of Nippon Sport Science University, Japan

Author Profile

Orchid

Early Academic Pursuits

Asahi Matsubara’s journey into academia and research began with a deep curiosity about human potential and a strong passion for sport psychology. From the earliest days of higher education, Asahi displayed a distinct interest in understanding the psychological intricacies that shape athletic performance and team dynamics. This passion led Asahi to pursue graduate studies at the esteemed Graduate School of Nippon Sport Science University, a leading institution recognized for producing top-tier sports professionals and researchers in Japan. During the formative academic years, Asahi honed critical thinking, empirical research skills, and a commitment to ethical scholarship, laying the foundation for a promising research-oriented career in sports and exercise psychology.

Professional Endeavors

Currently based at the Graduate School of Nippon Sport Science University, Asahi Matsubara is deeply engaged in both academic learning and empirical research. One of the key hallmarks of Asahi’s professional journey is the commitment to applying advanced psychological theories to real-world athletic settings. This includes investigating how leadership dynamics influence the behaviors and well-being of student-athletes—an area of study that has critical implications for both sports psychology and coaching practices in educational institutions.

In particular, Asahi’s recent work titled “Conditional process analysis of the impact of coach leadership on the voice of Japanese student-athletes”—published in the Asian Journal of Sport and Exercise Psychology (2025)—exemplifies a nuanced approach to understanding the psychological processes underlying athlete-coach interactions. The research not only reflects Asahi’s academic rigor but also emphasizes real-world relevance by focusing on the lived experiences of Japanese student-athletes.

Contributions and Research Focus

Asahi Matsubara’s primary research focus lies at the intersection of leadership psychology, athlete behavior, and educational sports systems. With a keen interest in voice behavior, Asahi explores how athletes express their ideas, concerns, or feedback to coaches, and how leadership styles either foster or inhibit such behaviors. Using sophisticated methodologies like conditional process analysis, Asahi’s research illuminates the mediating and moderating variables that shape this dynamic.

The publication of the 2025 journal article in a Scopus-indexed journal serves as a critical milestone in this research journey. Moreover, Asahi’s scholarly contributions reflect a dedication to data-driven insights that can transform coaching models in educational and professional sports institutions alike.

Beyond publishing, Asahi is actively involved in academic collaborations and maintains an interest in interdisciplinary approaches to sport science. With a citation index that is steadily growing, Asahi is carving out a reputation as a rising scholar in the sport and exercise psychology research community.

Accolades and Recognition

While still early in the professional journey, Asahi’s contributions have already begun to garner attention within academic circles. The nomination for the Best Researcher Award is a testament to the quality, originality, and impact of Asahi’s work. Recognition by peers and senior scholars is a significant milestone that affirms the value and relevance of Asahi’s contributions to the academic and sports communities.

Such acknowledgment is not only a personal achievement but also a motivator for continued excellence. It reinforces Asahi’s belief in the importance of scientific inquiry and its ability to create meaningful change in how we understand athletic performance and leadership.

Impact and Influence

Asahi Matsubara’s research goes beyond academic boundaries. By investigating psychological variables in coaching and athlete behavior, Asahi contributes to the development of healthier, more communicative, and empowered athletic environments. The implications of Asahi’s work extend to sports coaches, athletic trainers, school administrators, and policy-makers.

Student-athletes, especially in high-pressure academic contexts like Japan, benefit immensely from research that aims to enhance psychological safety and promote assertiveness. Through Asahi’s findings, institutions are better equipped to build trust-based relationships between coaches and athletes, ultimately leading to improved mental health and performance outcomes.

Legacy and Future Contributions

Looking ahead, Asahi Matsubara envisions a future filled with impactful contributions to the field of sport and exercise psychology. Plans are underway to expand current research themes into longitudinal studies, incorporating broader cultural variables and diverse athletic populations. Asahi is also eager to contribute to textbook development, academic teaching, and cross-institutional collaborations in Japan and internationally.

With a strong academic base, growing research portfolio, and commitment to social impact, Asahi aims to leave a legacy not just as a scholar, but as a transformational figure in educational sports systems. The long-term goal is to reshape coaching paradigms and champion athlete-centered practices that prioritize mental well-being and mutual respect.

Asahi Matsubara stands today not only as a researcher with promise but also as a symbol of the new generation of scholars—those who blend scientific excellence with societal relevance.

Notable Publications

Conditional process analysis of the impact of coach leadership on the voice of Japanese student-athletes

Author: Matsubara Asahi
Journal: Asian Journal of Sport and Exercise Psychology
Year: 2025

Prof. Dr. Xiaofeng Dai | Authentic Leadership | Best Researcher Award

Posted on 17/03/2025 by ScienceFather

Prof. Dr. Xiaofeng Dai | Authentic Leadership | Best Researcher Award

Xi’an Jiaotong University Medical College First Affiliated Hospital: The First Affiliated Hospital of Xi’an Jiaotong University, China

Author Profile

Scopus

Early Academic Pursuits

Dai Xiaofeng’s academic journey exemplifies a commitment to interdisciplinary research and innovation. His early studies took him to Tampere University of Technology, Finland, where he pursued a master’s degree in bioinformatics, and the Chinese Academy of Agricultural Sciences, where he earned a master’s degree in molecular biology. These foundational studies provided him with a solid background in computational and biological sciences, setting the stage for his later achievements. He further advanced his expertise by obtaining a Ph.D. in computational systems biology from Tampere University of Technology, focusing on genome-wide association studies (GWAS) and molecular mechanisms. Not content with a singular academic trajectory, he pursued a second Ph.D. in econometrics from Aalto University, Finland, where he applied computational biological methods to economic modeling. His doctoral education in genetics at the University of Helsinki added yet another layer to his multidisciplinary expertise.

Professional Endeavors and Research Focus

Following his extensive academic training, Dai Xiaofeng embarked on a research career that took him to the Finnish Center for Molecular Medicine and Helsinki Central Hospital, where he conducted postdoctoral research in GWAS and anti-cancer molecular mechanisms. These experiences allowed him to refine his expertise in genetic research and translational medicine. Upon his return to China, he established a pioneering research group at Xi’an Jiaotong University’s First Affiliated Hospital, focusing on the medical applications of Cold Atmospheric Pressure Plasma (CAP). His work in this domain has led to significant advancements in precision and translational medicine. He has investigated the multimodal anti-cancer molecular mechanisms of CAP and proposed a CAP redox balance model. His research also extends to the development of multi-dimensional anti-cancer tools, including the establishment of the first CAP database both domestically and internationally. He has played a crucial role in developing high-throughput, minimally invasive, and portable CAP medical devices, ensuring that these technologies can be effectively translated from research to real-world medical applications. His efforts to overcome technological barriers in CAP active preservation have further cemented his reputation as a leader in the field.

Contributions and Publications

Dai Xiaofeng’s contributions to scientific literature are substantial. He has authored 104 SCI-indexed papers as the first and/or corresponding author, with his work appearing in top-tier journals such as Signal Transduction and Targeted Therapy, Redox Biology, Progress in Polymer Science, Biotechnology Advances, Advanced Science, Free Radical Biology and Medicine, Computational Biology and Medicine, Trends in Biotechnology, and Trends in Genetics. His research, spanning over 110 internationally published articles, has amassed a total impact factor of 746, highlighting the significance of his findings in both medical and engineering disciplines.

Accolades and Recognition

Dai Xiaofeng’s innovative research has earned him numerous accolades. His groundbreaking work in CAP translational medicine has been recognized through prestigious research grants and awards, both in China and internationally. His expertise has led to invitations to speak at global conferences on plasma medicine, molecular biology, and biomedical engineering. In addition to his academic honors, his collaborations with leading medical institutions and engineering firms have further reinforced the importance of his research. His contributions to national healthcare policies, particularly through his work on CAP-based therapeutic applications, demonstrate his influence beyond academia.

Impact and Influence

Dai Xiaofeng’s interdisciplinary research has had a profound impact on multiple fields. His work in CAP-based cancer treatment has introduced non-invasive therapeutic modalities, offering new hope to patients. His contributions to medical device innovation have led to the development of cutting-edge plasma-based tools, which are poised to revolutionize the treatment landscape. His emphasis on translational medicine ensures that groundbreaking research is not confined to laboratories but reaches the clinical setting, where it can benefit real patients. Beyond his own research, he has dedicated himself to mentoring young scientists, fostering a new generation of researchers capable of bridging multiple scientific disciplines.

Legacy and Future Contributions

Dai Xiaofeng’s legacy is one of innovation, interdisciplinary collaboration, and a relentless pursuit of scientific advancement. Looking ahead, he aims to expand CAP-based therapeutics into broader clinical applications, ensuring that these technologies become a staple in modern medical treatment. His future work will focus on the integration of artificial intelligence into CAP devices, optimizing their therapeutic potential. Strengthening collaborations between academia, industry, and healthcare providers remains a priority, as does advocating for policy changes that support the integration of CAP technology into mainstream medical practice. Through his pioneering research, Dai Xiaofeng continues to shape the future of biomedical science, leaving an indelible mark on the fields of medicine, engineering, and computational biology.

Notable Publications

Spermidine antagonizes the anti-cancer effect of cold atmospheric plasma and induces transit G0/G1 cell cycle arrest of triple negative breast cancers
Authors: L. Shen, X. Lv, Y. Li, X. Dai
Journal: Free Radical Biology and Medicine
Year: 2025
Cold atmospheric plasma potentiates ferroptosis via EGFR(Y1068)-mediated dual axes on GPX4 among triple negative breast cancer cells
Authors: X. Dai, Z. Xu, X. Lv, M. Xi, T. Li
Journal: International Journal of Biological Sciences
Year: 2025
Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation
Authors: K. Zhu, Q. Lv, X. Lu, Y. Wang, X. Dai
Journal: Free Radical Biology and Medicine
Year: 2025
Metal-organic frameworks: potential synergies with cold atmospheric plasmas for cancer control
Authors: X. Dai, Y. Yang
Journal: Journal of Materials Chemistry B
Year: 2024
Magnetic nanoparticles and possible synergies with cold atmospheric plasma for cancer treatment
Authors: X. Dai, Y. Dai, Y. Zheng, Y. Lv
Journal: RSC Advances
Year: 2024